Who owns the NEXUS PHARMACEUTICALS trademark?

The NEXUS PHARMACEUTICALS trademark is owned by Nexus Pharmaceuticals, Inc..

What class is the NEXUS PHARMACEUTICALS trademark registered in?

The NEXUS PHARMACEUTICALS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for NEXUS PHARMACEUTICALS?

The USPTO serial number for NEXUS PHARMACEUTICALS is 88241191.

What is the registration number for NEXUS PHARMACEUTICALS?

NEXUS PHARMACEUTICALS is registered under USPTO registration number 5970504.

NEX

USPTO Trademark Record

REGISTERED

NEXUS PHARMACEUTICALS

SN 88241191·Reg 5970504·Filed Dec 25, 2018

Owner Nexus Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

NEXUS PHARMACEUTICALS (Serial No. 88241191), Registration No. 5970504, is a registered US trademark filed on Dec 25, 2018 by Nexus Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Section 8/9 declaration window: January 28, 2030

Mark Intelligence

NEXUS PHARMACEUTICALS (Reg. #5970504) is a registered US trademark that has been protecting its owner, Nexus Pharmaceuticals, Inc., since 2018. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 25, 2018

SERIAL

88241191

REG#

5970504

REGISTERED

Jan 28, 2020

Owner

Applicant

Nexus Pharmaceuticals, Inc.

Entity

Corporation

State

Address

400 Knightsbridge Parkway, Lincolnshire, IL, 60069

Country

Attorney

NameUmair A. Qadeer

Law firm

Umair A. Qadeer QADEER LLC

Docket

NEXUS.003TM2

Address

17 E. Monroe Street, Suite 114, Chicago, IL 60603, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateDec 25, 2018

Serial Number88241191

Registration No.5970504

Registration DateJan 28, 2020

Status DateApr 21, 2026

Published for OppositionNov 12, 2019

Next RenewalJanuary 28, 2030

Mark TypeDesign with words

Attorney DocketNEXUS.003TM2

Status DescriptionLive and registered, Section 8 and 15 accepted

Filing Signals

FILED

2018

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Aug 14, 2017

First use in commerce: Aug 14, 2017

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

22 events

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Apr 21, 2026

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Apr 21, 2026

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Apr 21, 2026

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

TEAS SECTION 8 & 15 RECEIVED

Jan 28, 2026

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jan 28, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Nov 29, 2023

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Nov 29, 2023

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Nov 29, 2023

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Jan 28, 2020

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Nov 12, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 12, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 23, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

Oct 09, 2019

LAW OFFICE PUBLICATION REVIEW COMPLETED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 08, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Oct 07, 2019

ASSIGNED TO LIE

ASSIGNED TO EXAMINER

Mar 18, 2019

ASSIGNED TO EXAMINER

SUSPENSION LETTER WRITTEN

Mar 18, 2019

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Mar 18, 2019

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Mar 18, 2019

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jan 18, 2019

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 17, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 28, 2018

NEW APPLICATION ENTERED

NEXUS PHARMACEUTICALS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Nexus Pharmaceuticals, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Umair A. Qadeer

Resources

Company